CIK 0000883975 · Non-accelerated filer<br>Smaller reporting company
Microbot Medical Inc.
Sign in to watch- Ticker
- MBOT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943078125
- Phone
- 908-938-5561
- Business address
- 25 RECREATION PARK DR SUITE 108, HINGHAM, MA, 02043
- Former names
- Microbot Medical Inc., STEMCELLS INC, CYTOTHERAPEUTICS INC/DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-26 | Vaknin Rachel Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +4,375 | 4,375 | ||
| 2024-02-26 | Sharon Simon General Manager, CTO | Grant or award · Stock Option (Right to Buy) | +8,750 | 8,750 | ||
| 2024-02-26 | Gadot Harel Chairman, President and CEO | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2024-02-26 | Diaz-Cartelle Juan Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +10,500 | 10,500 | ||
| 2024-02-26 | Gadot Harel Chairman, President and CEO | Grant or award · Stock Option (Right to Buy) | +79,567 | 79,567 | ||
| 2024-02-22 | Vaknin Rachel Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2024-02-22 | Vaknin Rachel Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2024-02-22 | Sharon Simon General Manager, CTO | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2024-02-22 | Sharon Simon General Manager, CTO | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2024-02-22 | Gadot Harel Chairman, President and CEO | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2024-02-22 | Gadot Harel Chairman, President and CEO | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2024-02-22 | Diaz-Cartelle Juan Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2023-11-02 | Bornstein Yoseph Director | Grant or award · Stock Option (Right to Buy) | +74,218 | 74,218 | ||
| 2023-11-02 | Burell Scott R Director | Grant or award · Stock Option (Right to Buy) | +74,218 | 74,218 | ||
| 2023-11-02 | Wenderow Tal Baruch Director | Grant or award · Stock Option (Right to Buy) | +74,218 | 74,218 | ||
| 2023-11-02 | Stockburger Aileen Ptucha Director | Grant or award · Stock Option (Right to Buy) | +74,218 | 74,218 | ||
| 2023-11-02 | Madden Martin J. Director | Grant or award · Stock Option (Right to Buy) | +74,218 | 74,218 | ||
| 2023-11-02 | Laxminarain Prattipati Director | Grant or award · Stock Option (Right to Buy) | +74,218 | 74,218 | ||
| 2023-08-01 | Sharon Simon General Manager, CTO | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2023-08-01 | Gadot Harel Chairman, President and CEO | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 |
Page 2 of 6 · 114 trades